Table 1 Patient and tumor characteristics.
N = 143 | |
|---|---|
Gender, n (%) | |
Male | 71 (49.7%) |
Female | 72 (50.3%) |
Age, median (range) (years) | 2.9 (0–19.6) |
Procedure performed for initial diagnosis, n (%) | |
Thoracoscopy/Thoracotomy | 90 (62.9%) |
Needle biopsy | 22 (15.4%) |
Unknown | 31 (21.7%) |
Pneumothorax at time of presentation, n (%) | |
Yes | 30 (21.0%) |
No | 68 (47.6%) |
Unknown | 45 (31.5%) |
Neoadjuvant therapy, n (%) | |
Yes | 99 (69.2%) |
No | 40 (28.0%) |
Unknown | 4 (2.8%) |
Margin status for primary surgical resection, n (%) | |
Positive | 61 (42.7%) |
Negative | 49 (34.3%) |
Unknown | 33 (23.1%) |
Pleuropulmonary blastoma histologic type, n (%) | |
Ir | 20 (14.0%) |
I | 33 (23.1%) |
II | 46 (32.2%) |
III | 44 (30.8%) |
Anaplasia, n (%) | |
Yes | 58 (40.6%) |
No | 85 (59.4%) |
Metastatic disease at time of presentation, n (%) | |
Yes | 7 (4.9%) |
No | 135 (95.1%) |
